Die Autoren danken Dr. Katharina Schallmoser für die Bereitstellung PHPL und Margaretha Frühwirth und Daniela Thaler für hervorragende technische Unterstützung.

A.) ECFC ISOLATON TAG 1: <ol><li> Bevor Sie mit Start der Vorbereitung des Experiments das Zellkulturmedium Endothelial Growth Medium-2 (EGM-2). Supplement 500ml Endothelial Basal Medium-2 mit Heparin (1ml von 1000 U / ml), 5ml 100x Lösung von Penicillin / Streptomycin (alle Sigma, St. Louis, MO; <a href="http://www.sigmaaldrich.com/">www.sigmaaldrich.com</a> ), L-Glutamin (2 mM Endkonzentration ) und 50 ml gepoolten menschlichen Thrombozyten-Lysat (PHPL). Dann fügen Sie 0,2 ml Hydrocortison, 2 ml hFGF-B, 0,5 ml VEGF, 0,5 ml EGF, 0,5 ml IGF-1 und 0,5 ml Ascorbinsäure (sofern als SingleQuots, alle Lonza, Walkersville, MD; <a href="http://www.lonzabioscience.com/">http://www.lonzabioscience. com /</a> ). Sterile Filtrat das Medium durch einen 0,2 m-Porengröße 500 ml Millipore Vakuum-Filter. Da PHPL bildet kleine Klumpen müssen Sie möglicherweise zwei Filtern für ein Medium. Pre-warm gefiltert EGM-2 bis 37 ° C im Wasserbad </li><li> Sammeln Sie die Blutproben, indem 5 ml der erwachsenen menschlichen peripheren Blut aus der Cubitalvene in eine 6ml Konservierungsstoffe Natrium-Heparin-Blut Vacutainer-Röhrchen. Sie sollten die Blutproben innerhalb von maximal zwei Stunden zu bearbeiten. </li><li> Beginnen Sie mit der Vorbereitung eine 75 cm 2 (T75; Costar) Kolben mit einem belüfteten Kappe, einer 25 ml Pipette und zwei 5 ml Pipetten in einer laminaren Strömung Bank. </li><li> Pre-fill 15 ml vorgewärmten EGM-2 in den Kolben ergänzt mit 25 ml Pipette. Öffnen Sie nun das Blut Fläschchen und Probe alle 5 ml mit 5 ml Pipette in den Kolben. Spülen Sie die leere Blut Fläschchen mit 5 ml zusätzliche EGM-2 mit dem zweiten 5 ml Pipette. Das Gesamtvolumen innerhalb der T75 ist 25 ml. Schließen Sie die entlüftet-Cap der Flasche und in einem Brutschrank bei 37 ° C, 5% CO 2 und 95% Luftfeuchtigkeit für 24 Stunden. </li></ol> TAG 2: <ol><li> Nach ca. 24 Stunden (über Nacht) sollten Sie entfernen die mittel-Blut-Gemisch, um loszuwerden, nicht adhärente Zellen. Für diese Ausarbeitung von zwei 25 ml Pipetten und drei 5-ml-Pipetten in der laminaren Strömung, pre-warme 20 ml ergänzt EGM-2 (vorbereitet vom Vortag) und 30 ml PBS auf 37 ° C in einem Wasserbad. </li><li> Entfernen Sie den Kolben mit der Probe aus dem Inkubator und entfernen Sie alle den Überstand mit einer 25 ml Pipette. Achten Sie darauf, den Kolben Oberfläche kratzen, um eine Beschädigung mögliche Kolonie. Waschen Sie den inneren Kolben Zelladhärenz Oberfläche dreimal durch vorsichtiges Zugeben von 10 ml vorgewärmtes PBS und Kippen des Kolbens von einer Seite zur anderen. Entfernen Sie die PBS sofort jeder Zeit und zu verwerfen. </li><li> 20 ml frisches vorgewärmtes EGM-2 in den Kolben und legen Sie sie zurück in den Inkubator. Dieser Prozess sollte so schnell und schonend wie möglich für die anhaftenden Zellen nicht zu lösen durchgeführt werden. ECFCs leicht lösen, wenn sie in PBS oder bei Raumtemperatur zu lange gehalten werden. </li><li> Bildschirm durch den Kolben systemisch jeden zweiten Tag ab Tag zwei mit einem geringer Vergrößerung eines Lichtmikroskops auf der Suche nach ECFC Auswuchs. Wenn eine Kolonie Marke auf der Oberseite zu finden an der Außenseite des Kolbens, der die Position der Kolonie. Beachten Sie, dass die Flaks sollte nicht außerhalb des Inkubators für mehr als 5 Minuten. </li></ol> TAG 5: <ol><li> Am fünften Tag nach der Aussaat eine vollständige mittlere Änderung nicht adhärente Zellen zu entfernen. Zu diesem Zweck vorwärmen 20 ml EGM-2 bis 37 ° C im Wasserbad und bereiten zwei 25-ml-Pipetten. </li><li> Entfernen Sie den vollständigen Medium mit einer 25 ml Pipette und fügen frische, vorgewärmte ergänzt EGM-2 so schnell wie möglich. Die Zellen sollten nicht ohne Medium für mehr als eine Minute, um zu vermeiden Trocknen gelassen werden. Legen Sie wieder in den Inkubator und wiederholen Screening der Flasche täglich. </li><li> Feed the-Zellen durch den Ersatz von 30% des Mediums durch frisches ergänzt EGM-2-mal wöchentlich. </li></ol> TAG 14-28: <ol><li> Typische Kolonien mit Kopfsteinpflaster Morphologie sollte etwa 12 Tage angezeigt werden. Mark der oberen Außenseite des Kolbens auf die Position der einzelnen Kolonie zeigen. Lassen Sie den Kolonien bis Tag 28 wachsen, wenn einzelne Zellen zu lösen beginnen. Einmal, sind in erster Linie Kolonien identifiziert sie zwischen den Tagen 14 und 28 geerntet werden kann, abhängig von ihrer Größe. </li></ol> B.) ECFC HARVEST <ol><li> Pre-warm 5 ml Trypsin 0,05% / EDTA, 20 ml PBS und 5 ml frisch ergänzt EGM-2. </li><li> Vollständig zu entfernen Medium aus der Flasche in ein Falcon-Röhrchen (Vorsicht, nicht an der Oberfläche des Kolbens nicht zu beschädigen mögliche Kolonie touch) und waschen Sie die Zellen vorsichtig mit 10 ml vorgewärmter PBS. </li><li> 5 ml Trypsin / EDTA und Inkubation für 5 Minuten in den Inkubator. Die Zellen sollten nicht auf Trypsin für mehr als 7 min ausgesetzt werden, da es giftig wird. Gründlich Antippen der Seiten des Kolbens hilft Zellen zu lösen. Quench Trypsin-Protease-Aktivität durch Zugabe von ca. 10 ml der erhaltenen verwendet Kulturmedium. </li><li> Entfernen Zellsuspension in eine 50 ml Falcon Rohr. Waschen Sie die Flasche einmal mit 10 ml PBS, die danach auf den geernteten Zellsuspension zugegeben. Centrifuge die Zellsuspension bei 300 g für 7 min bei 4 ° C zu sammeln die Zellen und entfernen Sie die Trypsin. Überstand verwerfen und Zellpellet sofort in 1 ml PBS. Keep on ice. </li><li> Bestimmen der Zellzahl, wie in einem JoVE Protokoll, das von R. Ricardo und K. Phelani beschrieben. 5 </li></ol> C) ECFC EXPANSION <ol><li> Supplement 500 ml EGM-2 als in A 1.1 beschrieben). Pre-warm bis 37 ° C in einem Wasserbad. </li><li> Für etwa 2500 cm 2 Kultur Raum bereiten entweder 11 T220 (225 cm 2) oder 15 T175 (175 cm 2) oder einer vierschichtigen Zellfabrik (CF-4; Nunc, Naperville, IL; <a href="http://www.nuncbrand.com/">http://www.nuncbrand . com</a> ). Zusätzlich benötigen Sie zwei frische Luft-caps und einer speziellen sterilen Trichter in der Laminar-Flow-bench. </li><li> Um Samen ECFCs bei einem Ausgangs-Zelldichte von 100 c / cm 2 Berechnung der Zellzahl ist notwendig. Zum einen CF-4 252800 Zellen werden in 500 ml frisches EGM-2 resuspendiert und ergossen sich in die CF-4 mit dem sterilen Trichter. Schließen Sie eine Entlüftung mit der vent-Kappe und kippen Sie das CF-4 zu einer Länge Seite, so dass eine gleichmäßige Verteilung des Mediums zwischen allen 4 Mehle. Dann kippen die Kammer zurück und öffnen Sie den Deckel des vent-cap. Legen Sie CF-4 in Inkubator. </li><li> Ändern Sie 20% des Mediums mindestens einmal wöchentlich, bis CF-4 ist konfluent. </li><li> Ernten Sie die Zellen wie in B beschrieben) mit 70 ml Trypsin / EDTA und ca. 200 ml PBS. </li></ol> Repräsentative Ergebnisse Mit dieser Trennung Methode beobachteten wir eine primäre Koloniebildung am Tag 12. In einer früheren Studie konnten auf einen Mittelwert von 4,0 ± 0,8 ECFC-Kolonien aus jeder ml der peripheren Blut gewonnen zu erholen. 4 ECFCs zeigte eine typische Kopfsteinpflaster Aussehen. Nach großräumige Ausdehnung, mit einer Aussaatdichte von 100 Zellen / cm 2, erhalten wir&gt; 1 x 10 8 Zellen in insgesamt rund 30 Tage aus 3 männlichen und 1 weiblichen Probanden (Alter zwischen 26 und 50 Jahre). ECFC unter diesen Bedingungen kultiviert wurden gezeigt, dass proliferative, funktional und genomisch stabil. 4 Darüber Zellen gespeichert werden kann (in 10% DMSO) in flüssigem Stickstoff für die weitere Verwendung sein. 3,4

<ol>
	<li>Solovey, A., Lin, Y., Browne, P., Choong, S., Wayner, E., Hebbel, R. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Circulating+activated+endothelial+cells+in+sickle+cell+anemia.">Circulating activated endothelial cells in sickle cell anemia.</a> N Engl J Med. 337, 1584-1590 (1997).</li><li>Yoder, M. C., Mead, L. E., Prater, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Redefining+endothelial+progenitor+cells+via+clonal+analysis+and+hematopoietic+stem/progenitor+cell+principals.">Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.</a> Blood. 109, 1801-1809 (2007).</li><li>Schallmoser, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+large-scale+expansion+of+functional+mesenchymal+stem+cells+from+unmanipulated+bone+marrow+without+animal+serum.">Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.</a> Tissue Eng Part C Methods. 14, 185-196 (2008).</li><li>Reinisch, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Humanized+large-scale+expanded+endothelial+colony-forming+cells+function+in+vitro+and+in+vivo.">Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.</a> Blood. , (2009).</li><li>Ricardo, R., Phelan, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Counting+and+Determining+the+Viability+of+Cultured+Cells.">Counting and Determining the Viability of Cultured Cells.</a> J Vis Exp. , (2008).</li></ol>

Diese neuartige Isolierung und Expansion Methode ist ein einfaches und effizientes Verfahren, die effizienter und weniger zeitaufwendig, indem es jegliche Zellseparation (keine Dichtegradienten erforderlich) und weniger teuer als herkömmliche Techniken. Durch die Verwendung von PHPL Kontakt zu Rindern Antigene und vermeintlichen späteren xenoimmunization ist ausgeschlossen. Während der Kulturzeit kleine Blutgerinnsel bilden können, die durch die PHPL. Basierend auf unserer Erfahrung diese Blutgerinnsel haben keinen ...

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">	
		
		<div>
		<table border="1">
		<thead>
		<tr>
		<th>Material Name</th>
		<th>Type</th>
		<th>Company</th>
		<th>Catalogue Number</th>
		<th>Comment</th>
		</tr>
		</thead>
		<tbody>
		
<tr>
<td>Endothelial basal Medium-2</td>
<td>&nbsp;</td>
<td>Lonza</td>
<td>&nbsp;</td>
<td>500ml</td>
</tr>
<tr>
<td>EGM-2 SingleQuots</td>
<td>&nbsp;</td>
<td>Lonza</td>
<td>&nbsp;</td>
<td>EGF, hFGF-B, VEGF, IGF-1, Hydrocortisone, ascorbic acid</td>
</tr>
<tr>
<td>preservative-free Heparin</td>
<td>&nbsp;</td>
<td>Biochrom AG</td>
<td>&nbsp;</td>
<td>10U/ml per EGM-2</td>
</tr>
<tr>
<td>L-Glutamine</td>
<td>&nbsp;</td>
<td>Sigma </td>
<td>&nbsp;</td>
<td>2mM per EGM-2</td>
</tr>
<tr>
<td>Penicillin and Streptomycin</td>
<td>&nbsp;</td>
<td>Sigma </td>
<td>&nbsp;</td>
<td>100U/mL Penicillin and 100&mu;g/mL Streptomycin per EGM-2</td>
</tr>
<tr>
<td>Trypsin/1mM EDTA </td>
<td>&nbsp;</td>
<td>Gibco Cell Culture, Invitrogen </td>
<td>&nbsp;</td>
<td>7ml for T75 flask 70ml for CF-4</td>
</tr>
<tr>
<td>PBS</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>Four-layered cell factory (CF-4) </td>
<td>&nbsp;</td>
<td>Corning</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>Sterile Funnel</td>
<td>&nbsp;</td>
<td>Corning</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>T75cm2 culture flask (with vented cap)</td>
<td>&nbsp;</td>
<td>Corning</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>6 mL vacutainer tubes (preservative-free sodium heparin) </td>
<td>&nbsp;</td>
<td>Becton Dickenson</td>
<td>&nbsp;</td>
<td>preloaded with 108 IU/6ml of preservative-free sodium heparin</td>
</tr>
<tr>
<td>50ml Falcon tubes</td>
<td>&nbsp;</td>
<td>Falcon</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>5ml Stripetts</td>
<td>&nbsp;</td>
<td>Costar</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>25ml Stripetts</td>
<td>&nbsp;</td>
<td>Costar</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>Squeezer</td>
<td>&nbsp;</td>
<td>Costar</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<tr>
<td>0,2 pore size sterile filter</td>
<td>&nbsp;</td>
<td>Millipore</td>
<td>&nbsp;</td>
<td>2x 500ml per EGM-2</td>
</tr>		</tbody>
		</table>
		</div>

isolation and large scale expansion of adult human endothelial colony forming progenitor cells

Dieser Beitrag stellt eine neuartige Recovery-Strategie für die endotheliale koloniebildenden Progenitorzellen (ECFCs) aus heparinisiertem aber ansonsten unmanipulierten erwachsenen menschlichen peripheren Blut innerhalb einer im Mittel 12 Tage. Nach großräumige Ausdehnung&gt; 1x10 8 ECFCs können für weitere Tests gewonnen werden. Vorteilhaft mit PHPL den Kontakt von menschlichen Zellen mit Rinderserum Antigene ausgeschlossen werden kann. Mittels Durchflusszytometrie und Immunhistochemie die isolierten Zellen können als ECFC und ihre in vitro-Funktionalität zu vaskulären Strukturen bilden können in einer Matrigel-Assay getestet werden charakterisiert werden. Weitere können diese Zellen subkutan in einem Mausmodell injiziert werden, um funktionelle, perfundierten Gefäßen in vivo zu bilden. Nach langfristige Expansion und Kryokonservierung Proliferation, erscheinen Funktion und genomische Stabilität zu erhalten. 3,4 Dieses Tier-Protein-freie Isolierung und Expansion Methode ist leicht anwendbar, um eine große Menge an ECFCs generieren.

Watch this Scientific Journal Video about Isolation and Large Scale Expansion of Adult Human Endothelial Colony Forming Progenitor Cells at JoVE.com

Isolation and Large Scale Expansion of Adult Human Endothelial Colony Forming Progenitor Cells

Endothelial koloniebildenden Progenitorzellen (ECFCs) sind ein viel versprechendes Instrument, um vaskuläre Homöostase und Reparatur zu studieren.<sup&gt; 1,2</sup&gt; Dieser Beitrag stellt eine neuartige Tier-serumfreien Verfahren zur Isolierung und Expansion von ECFC aus heparinisiertem erwachsenen menschlichen peripheren Blut mit gepoolten menschlichen Thrombozyten-Lysat (PHPL) vermindert das Risiko von Anti-Rinder-Impfung.

Isolation und großräumige Ausdehnung der erwachsenen Menschen Endothelial Colony Forming Progenitorzellen

This paper introduces a novel recovery strategy for endothelial colony forming progenitor cells (ECFCs) from heparinized but otherwise unmanipulated adult ...

isolation-large-scale-expansion-adult-human-endothelial-colony

Research

JoVE Journal

Biology

10.7K Aufrufe.  Medical University of Graz, Austria. Endothelial koloniebildenden Progenitorzellen (ECFCs) sind ein viel versprechendes Instrument, um vaskuläre Homöostase und Reparatur zu studieren. 1,2 Dieser Beitrag stellt eine neuartige Tier-serumfreien Verfahren zur Isolierung und Expansion von ECFC aus heparinisiertem erwachsenen menschlichen peripheren Blut mit gepoolten menschlichen Thrombozyten-Lysat (PHPL) vermindert das Risiko von Anti-Rinder-Impfung.

Serie: Isolation and Large Scale Expansion of Adult Human Endothelial Colony Forming Progenitor Cells

Isolation of Human Umbilical Vein Endothelial Cells (HUVEC)

Angiogenesis is a complex multi-step process, where in response to angiogenic stimuli, new vessels are created from the existing vasculature. These steps include: degradation of the basement membrane, proliferation and migration (sprouting) of endothelial cells (EC) into the extracellular matrix, alignment of EC into cords, lumen formation, anastomosis, and formation of a new basement membrane. Many in vitro assays have been developed to study this process, but most only mimic certain stages of angiogenesis, and morphologically the vessels often do not resemble vessels in vivo. Here we demonstrate an optimized in vitro angiogenesis assay that utilizes human umbilical vein EC and fibroblasts. This model recapitulates all of the key early stages of angiogenesis, and importantly the vessels display patent intercellular lumens surrounded by polarized EC. Vessels can be easily observed by phase-contrast and time-lapse microscopy, and recovered in pure form for downstream applications.

Isolation of Human Umbilical Vein Endothelial Cells HUVEC

This video protocol illustrates the isolation and culture of human umbilical vein endothelial cells (HUVEC) from human umbilical cord. Once isolated these cells can be used for in vitro angiogenesis assays like the Optimized Fibrin Gel Bead Assay also demonstrated by the Hughes lab.

Isolierung humaner Nabelschnur-Endothelzellen (HUVEC)

Angiogenesis is a complex multi-step process, where in response to angiogenic stimuli, new vessels are created from the existing vasculature. These steps ...

Forschung

Biologie

Large-Scale Screens of Metagenomic Libraries

Metagenomic libraries archive large fragments of contiguous genomic sequences from microorganisms without requiring prior cultivation. Generating a streamlined procedure for creating and screening metagenomic libraries is therefore useful for efficient high-throughput investigations into the genetic and metabolic properties of uncultured microbial assemblages. Here, key protocols are presented on video, which we propose is the most useful format for accurately describing a long process that alternately depends on robotic instrumentation and (human) manual interventions. First, we employed robotics to spot library clones onto high-density macroarray membranes, each of which can contain duplicate colonies from twenty-four 384-well library plates. Automation is essential for this procedure not only for accuracy and speed, but also due to the miniaturization of scale required to fit the large number of library clones into highly dense spatial arrangements. Once generated, we next demonstrated how the macroarray membranes can be screened for genes of interest using modified versions of standard protocols for probe labeling, membrane hybridization, and signal detection. We complemented the visual demonstration of these procedures with detailed written descriptions of the steps involved and the materials required, all of which are available online alongside the video.

Large-Scale-Bildschirme von Metagenombanken

Metagenomic libraries archive large fragments of contiguous genomic sequences from microorganisms without requiring prior cultivation.  Generating a ...

Isolation and Animal Serum Free Expansion of Human Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) and Endothelial Colony Forming Progenitor Cells (ECFCs)

The umbilical cord is a rich source for progenitor cells with high proliferative potential including mesenchymal stromal cells (also termed mesenchymal stem cells, MSCs) and endothelial colony forming progenitor cells (ECFCs). Both cell types are key players in maintaining the integrity of tissue and are probably also involved in regenerative processes and tumor formation.
To study their biology and function in a comparative manner it is important to have both cells types available from the same donor. It may also be beneficial for regenerative purposes to derive MSCs and ECFCs from the same tissue.
Because cellular therapeutics should eventually find their way from bench to bedside we established a new method to isolate and further expand progenitor cells without the use of animal protein. Pooled human platelet lysate (pHPL) replaced fetal bovine serum in all steps of our protocol to completely avoid contact of the cells to xenogeneic proteins.
This video demonstrates a methodology for the isolation and expansion of progenitor cells from one umbilical cord.
All materials and procedures will be described.

Isolation and Animal Serum Free Expansion of Human Umbilical Cord Derived Mesenchymal Stromal Cells MSCs and Endothelial Colony Forming Progenitor Cells ECFCs

This protocol describes the isolation and subsequent expansion of mesenchymal stromal cells and endothelial colony forming cells without the use of animal serum to generate autologous pairs for experimental transplantation purposes.

Isolation und tierisches Serum Freie Expansion der menschlichen Nabelschnur Derived mesenchymale Stromazellen (MSCs) und Endothelial Colony Forming Progenitorzellen (ECFCs)

The umbilical cord is a rich source for progenitor cells with high proliferative potential including mesenchymal stromal cells (also termed mesenchymal ...

Isolation of Valvular Endothelial Cells

Heart valves are solely responsible for maintaining unidirectional blood flow through the cardiovascular system. These thin, fibrous tissues are subjected to significant mechanical stresses as they open and close several billion times over a lifespan. The incredible endurance of these tissues is due to the resident valvular endothelial (VEC) and interstitial cells (VIC) that constantly repair and remodel in response to local mechanical and biological signals. Only recently have we begun to understand the unique behaviors of these cells, for which in vitro experimentation has played a key role. Particularly challenging is the isolation and culture of VEC. Special care must be used from the moment the tissue is removed from the host through final plating. Here we present protocols for direct isolation, side specific isolation, culture, and verification of pure populations of VEC. We use enzymatic digestion followed by a gentle swab scraping technique to dislodge only surface cells. These cells are then collected into a tube and centrifuged into a pellet. The pellet is then resuspended and plated into culture flasks pre-coated with collagen I matrix. VEC phenotype is confirmed by contact inhibited growth and the expression of endothelial specific markers such as PECAM1 (CD31), Von Willebrand Factor (vWF), and negative expression of alpha-smooth muscle actin (&alpha;-SMA). The functional characteristics of VEC are associated with high levels of acetylated LDL. Unlike vascular endothelial cells, VEC have the unique capacity to transform into mesenchyme, which normally occurs during embryonic valve formation1. This can also occur during significantly prolonged post confluent in vitro culture, so care should be made to passage at or near confluence. After VEC isolation, pure populations of VIC can then be easily acquired.

We provide a method for isolating and culturing pure populations of heart valve endothelial cells (VEC). VEC can be isolated from either side of the cusp or leaflet and immediately following, underlying interstitial cell (VIC) isolation is straightforward.

Isolierung von Valvular Endothelzellen

Heart valves are solely responsible for maintaining unidirectional blood flow through the cardiovascular system.  These thin, fibrous tissues are ...

Isolation and Culture of Avian Embryonic Valvular Progenitor Cells

Proper formation and function of embryonic heart valves is critical for developmental progression. The early embryonic heart is a U-shaped tube of endocardium surrounded by myocardium. The myocardium secretes cardiac jelly, a hyaluronan-rich gelatinous matrix, into the atrioventricular (AV) junction and outflow tract (OFT) lumen. At stage HH14 valvulogenesis begins when a subset of endocardial cells receive signals from the myocardium, undergo endocardial to mesenchymal transformation (EMT), and invade the cardiac jelly. At stage HH25 the valvular cushions are fully mesenchymalized, and it is this mesenchyme that eventually forms the valvular and septal apparatus of the heart. Understanding the mechanisms that initiate and modulate the process of EMT and cell differentiation are important because of their connection to serious congenital heart defects. In this study we present methods to isolate pre-EMT endocardial and post-EMT mesenchymal cells, which are the two different cell phenotypes of the prevalvular cushion. Pre-EMT endocardial cells can be cultured with or without the myocardium. Post-EMT AV cushion mesenchymal cells can be cultured inside mechanically constrained or stress-free collagen gels. These 3D in vitro models mimic key valvular morphogenic events and are useful for deconstructing the mechanisms of early and late stage valvulogenesis.

This article will provide a method for isolating and culturing quail or chicken HH14- valve endocardial cells and HH25 valve cushion mesenchymal cells.

Isolierung und Kultivierung von Avian Embryonale Valvular Progenitorzellen

Proper formation and function of embryonic heart valves is critical for developmental progression. The early embryonic heart is a U-shaped tube of ...

Isolation and Culture of Adult Epithelial Stem Cells from Human Skin

The homeostasis of all self-renewing tissues is dependent on adult stem cells. As undifferentiated stem cells undergo asymmetric divisions, they generate daughter cells that retain the stem cell phenotype and transit-amplifying cells (TA cells) that migrate from the stem cell niche, undergo rapid proliferation and terminally differentiate to repopulate the tissue.
Epithelial stem cells have been identified in the epidermis, hair follicle, and intestine as cells with a high in vitro proliferative potential and as slow-cycling label-retaining cells in vivo 1-3. Adult, tissue-specific stem cells are responsible for the regeneration of the tissues in which they reside during normal physiologic turnover as well as during times of stress 4-5. Moreover, stem cells are generally considered to be multi-potent, possessing the capacity to give rise to multiple cell types within the tissue 6. For example, rodent hair follicle stem cells can generate epidermis, sebaceous glands, and hair follicles 7-9. We have shown that stem cells from the human hair follicle bulge region exhibit multi-potentiality 10.
Stem cells have become a valuable tool in biomedical research, due to their utility as an in vitro system for studying developmental biology, differentiation, tumorigenesis and for their possible therapeutic utility. It is likely that adult epithelial stem cells will be useful in the treatment of diseases such as ectodermal dysplasias, monilethrix, Netherton syndrome, Menkes disease, hereditary epidermolysis bullosa and alopecias 11-13. Additionally, other skin problems such as burn wounds, chronic wounds and ulcers will benefit from stem cell related therapies 14,15. Given the potential for reprogramming of adult cells into a pluripotent state (iPS cells)16,17, the readily accessible and expandable adult stem cells in human skin may provide a valuable source of cells for induction and downstream therapy for a wide range of disease including diabetes and Parkinson's disease.

A rapid, robust way of isolating viable adult epithelial stem cells from human skin is described. The method utilizes enzymatic digestion of skin collagen matrix , followed by plucking of hair follicles and isolation of single cell suspensions or tissue fragments for cell culture.

Isolierung und Kultivierung von Adult epithelialen Stammzellen aus menschlicher Haut

The homeostasis of all self-renewing tissues is dependent on adult stem cells. As undifferentiated stem cells undergo asymmetric divisions, they generate ...

A Quantitative Assay for Insulin-expressing Colony-forming Progenitors

The field of pancreatic stem and progenitor cell biology has been hampered by a lack of in vitro functional and quantitative assays that allow for the analysis of the single cell. Analyses of single progenitors are of critical importance because they provide definitive ways to unequivocally demonstrate the lineage potential of individual progenitors. Although methods have been devised to generate "pancreatospheres" in suspension culture from single cells, several limitations exist. First, it is time-consuming to perform single cell deposition for a large number of cells, which in turn commands large volumes of culture media and space. Second, numeration of the resulting pancreatospheres is labor-intensive, especially when the frequency of the pancreatosphere-initiating progenitors is low. Third, the pancreatosphere assay is not an efficient method to allow both the proliferation and differentiation of pancreatic progenitors in the same culture well, restricting the usefulness of the assay.
To overcome these limitations, a semi-solid media based colony assay for pancreatic progenitors has been developed and is presented in this report. This method takes advantage of an existing concept from the hematopoietic colony assay, in which methylcellulose is used to provide viscosity to the media, allowing the progenitor cells to stay in three-dimensional space as they undergo proliferation as well as differentiation. To enrich insulin-expressing colony-forming progenitors from a heterogeneous population, we utilized cells that express neurogenin (Ngn) 3, a pancreatic endocrine progenitor cell marker. Murine embryonic stem (ES) cell-derived Ngn3 expressing cells tagged with the enhanced green fluorescent protein reporter were sorted and as many as 25,000 cells per well were plated into low-attachment 24-well culture dishes. Each well contained 500 &mu;L of semi-solid media with the following major components: methylcellulose, Matrigel, nicotinamide, exendin-4, activin &beta;B, and conditioned media collected from murine ES cell-derived pancreatic-like cells. After 8 to 12 days of culture, insulin-expressing colonies with distinctive morphology were formed and could be further analyzed for pancreatic gene expression using quantitative RT-PCR and immunoflourescent staining to determine the lineage composition of each colony.
In summary, our colony assay allows easy detection and quantification of functional progenitors within a heterogeneous population of cells. In addition, the semi-solid media format allows uniform presentation of extracellular matrix components and growth factors to cells, enabling progenitors to proliferate and differentiate in vitro. This colony assay provides unique opportunities for mechanistic studies of pancreatic progenitor cells at the single cell level.

A three-dimensional clonogenic assay that allows pancreatic-like progenitors to differentiate into insulin-expressing colonies is described. This method takes advantage of semi-solid media containing methylcellulose, Matrigel and growth factors, in which single progenitors proliferate and differentiate in vitro, permitting quantification of the number of functional progenitors in a population.

A Quantitative Assay für Insulin-exprimierenden Koloniebildende Vorläufern

The field of pancreatic stem and progenitor cell biology has been hampered by a lack of in vitro functional and quantitative assays that allow for the ...

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Longstanding views of new blood vessel formation via angiogenesis, vasculogenesis, and arteriogenesis have been recently reviewed1. The presence of circulating endothelial progenitor cells (EPCs) were first identified in adult human peripheral blood by Asahara et al. in 1997 2 bringing an infusion of new hypotheses and strategies for vascular regeneration and repair. EPCs are rare but normal components of circulating blood that home to sites of blood vessel formation or vascular remodeling, and facilitate either postnatal vasculogenesis, angiogenesis, or arteriogenesis largely via paracrine stimulation of existing vessel wall derived cells3. No specific marker to identify an EPC has been identified, and at present the state of the field is to understand that numerous cell types including proangiogenic hematopoietic stem and progenitor cells, circulating angiogenic cells, Tie2+ monocytes, myeloid progenitor cells, tumor associated macrophages, and M2 activated macrophages participate in stimulating the angiogenic process in a variety of preclinical animal model systems and in human subjects in numerous disease states4, 5. Endothelial colony forming cells (ECFCs) are rare circulating viable endothelial cells characterized by robust clonal proliferative potential, secondary and tertiary colony forming ability upon replating, and ability to form intrinsic in vivo vessels upon transplantation into immunodeficient mice6-8. While ECFCs have been successfully isolated from the peripheral blood of healthy adult subjects, umbilical cord blood (CB) of healthy newborn infants, and vessel wall of numerous human arterial and venous vessels 6-9, CB possesses the highest frequency of ECFCs7 that display the most robust clonal proliferative potential and form durable and functional blood vessels in vivo8, 10-13. While the derivation of ECFC from adult peripheral blood has been presented14, 15, here we describe the methodologies for the derivation, cloning, expansion, and in vitro as well as in vivo characterization of ECFCs from the human umbilical CB.

Endothelial colony forming cells (ECFCs) are circulating endothelial cells with robust clonal proliferative potential that display intrinsic in vivo vessel forming ability. Phenotypic and functional characterization of outgrowth endothelial cells derived from CB are important to identify and isolate bona fide ECFCs for potential clinical application in repairing damaged tissues.

Phänotypische und funktionelle Charakterisierung von Endothelial Kolonie-bildenden Zellen aus humanem Nabelschnurblut

Longstanding views of new blood vessel formation via angiogenesis, vasculogenesis, and arteriogenesis have been recently reviewed1. The presence of ...

Na&iuml;ve Adult Stem Cells Isolation from Primary Human Fibroblast Cultures

Over the last decade, several adult stem cell populations have been identified in human skin 1-4. The isolation of multipotent adult dermal precursors was first reported by Miller F. D laboratory 5, 6. These early studies described a multipotent precursor cell population from adult mammalian dermis 5. These cells--termed SKPs, for skin-derived precursors-- were isolated and expanded from rodent and human skin and differentiated into both neural and mesodermal progeny, including cell types never found in skin, such as neurons 5. Immunocytochemical studies on cultured SKPs revealed that cells expressed vimentin and nestin, an intermediate filament protein expressed in neural and skeletal muscle precursors, in addition to fibronectin and multipotent stem cell markers 6. Until now, the adult stem cells population SKPs have been isolated from freshly collected mammalian skin biopsies.
Recently, we have established and reported that a population of skin derived precursor cells could remain present in primary fibroblast cultures established from skin biopsies 7. The assumption that a few somatic stem cells might reside in primary fibroblast cultures at early population doublings was based upon the following observations: (1) SKPs and primary fibroblast cultures are derived from the dermis, and therefore a small number of SKP cells could remain present in primary dermal fibroblast cultures and (2) primary fibroblast cultures grown from frozen aliquots that have been subjected to unfavorable temperature during storage or transfer contained a small number of cells that remained viable 7. These rare cells were able to expand and could be passaged several times. This observation suggested that a small number of cells with high proliferation potency and resistance to stress were present in human fibroblast cultures 7.
We took advantage of these findings to establish a protocol for rapid isolation of adult stem cells from primary fibroblast cultures that are readily available from tissue banks around the world (Figure 1). This method has important significance as it allows the isolation of precursor cells when skin samples are not accessible while fibroblast cultures may be available from tissue banks, thus, opening new opportunities to dissect the molecular mechanisms underlying rare genetic diseases as well as modeling diseases in a dish.

Na&#239;ve Adult Stem Cells Isolation from Primary Human Fibroblast Cultures

We report a method to isolate na&#239;ve multipotent skin-derived precursor (SKP) cells from primary human fibroblast cultures. We show that these SKPs derived from fibroblast cultures share similar stem cell properties to the ones derived directly from human skin biopsies. These cells express the neural crest marker, nestin, in addition to the multipotent markers such as OCT4 and Nanog.

Naive Adult Stem Cells Isolation von primären humanen Fibroblasten Kulturen

Over the last decade, several adult stem cell  populations have been identified in human skin 1-4.  The isolation of multipotent adult dermal precursors ...

Isolation of Embryonic Ventricular Endothelial Cells

Cell culture has greatly enhanced our ability to assess individual populations of cells under myriad culture conditions. While immortalized cell lines offer significant advantages for their ease of use, these cell lines are unavailable for all potential cell types. By isolating primary cells from a specific region of interest, particularly from a transgenic mouse, more nuanced studies can be performed. The basic technique involves dissecting the organ or partial organ of interest (e.g. the heart or a specific region of the heart) and dissociating the organ to single cells. These cells are then incubated with magnetic beads conjugated to an antibody that recognizes the cell type of interest. The cells of interest can then be isolated with the use of a magnet, with a short trypsin incubation dissociating the cells from the beads. These isolated cells can then be cultured and analyzed as desired. This technique was originally designed for adult mouse organs but can be easily scaled down for use with embryonic organs, as demonstrated herein. Because our interest is in the developing coronary vasculature, we wanted to study this population of cells during specific embryonic stages. Thus, the original protocol had to be modified to be compatible with the small size of the embryonic ventricles and the low potential yield of endothelial cells at these developmental stages. Utilizing this scaled-down approach, we have assessed coronary plexus remodeling in transgenic embryonic ventricular endothelial cells.

Primary cell culture is a useful technique for analyzing specific populations of cells, particularly from transgenic mouse embryos at specific developmental stages. Herein, embryonic ventricles are dissected and dissociated, and antibody-conjugated beads recognize and separate out the endothelial cells for further analysis.

Isolierung von embryonalen ventrikuläre Endothelzellen

Cell culture has greatly enhanced our ability to assess individual populations of cells under myriad culture conditions. While immortalized cell lines ...